Melanoma Vaccines in Development: Looking to the Future.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 227, doi. 10.2165/00063030-200013040-00001
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2000 AND VI 13 AND IP 4
Results: 8
1
2
Anti-Interleukin-12 Antibody: Potential Role in Preventing Relapses of Multiple Sclerosis.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 233, doi. 10.2165/00063030-200013040-00002
- By:
- Publication type:
- Article
3
Common Variable Immunodeficiency: An Update on Therapeutic Approaches.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 243, doi. 10.2165/00063030-200013040-00003
- By:
- Publication type:
- Article
4
Use of Thalidomide in Dermatological Indications.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 255, doi. 10.2165/00063030-200013040-00004
- By:
- Publication type:
- Article
5
Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo: Characterisation of Drugs with an Increased Benefit-Risk Ratio.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 267, doi. 10.2165/00063030-200013040-00005
- By:
- Publication type:
- Article
6
Exhaled Nitric Oxide Levels in Childhood Asthma: A More Reliable Indicator of Asthma Severity than Lung Function Measurement?
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 279, doi. 10.2165/00063030-200013040-00006
- By:
- Publication type:
- Article
7
Recombinant Clotting Factors: A Review of Current Clinical Status.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 289, doi. 10.2165/00063030-200013040-00007
- By:
- Publication type:
- Article
8
Interferon-α Alone versus Interferon-α plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon-α Treatment.
- Published in:
- BioDrugs, 2000, v. 13, n. 4, p. 299, doi. 10.2165/00063030-200013040-00008
- By:
- Publication type:
- Article